These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21285972)

  • 21. Characterization of the molecular interactions of interleukin-8 (CXCL8), growth related oncogen alpha (CXCL1) and a non-peptide antagonist (SB 225002) with the human CXCR2.
    Catusse J; Liotard A; Loillier B; Pruneau D; Paquet JL
    Biochem Pharmacol; 2003 Mar; 65(5):813-21. PubMed ID: 12628493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterising the prognostic potential of HLA-DR during colorectal cancer development.
    Dunne MR; Phelan JJ; Michielsen AJ; Maguire AA; Dunne C; Martin P; Noonan S; Tosetto M; Geraghty R; Fennelly D; Sheahan K; Ryan EJ; O'Sullivan J
    Cancer Immunol Immunother; 2020 Aug; 69(8):1577-1588. PubMed ID: 32306077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Crucial Role of CXCL8 and Its Receptors in Colorectal Liver Metastasis.
    Bie Y; Ge W; Yang Z; Cheng X; Zhao Z; Li S; Wang W; Wang Y; Zhao X; Yin Z; Li Y
    Dis Markers; 2019; 2019():8023460. PubMed ID: 31827643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Periostin expression in intra-tumoral stromal cells is prognostic and predictive for colorectal carcinoma via creating a cancer-supportive niche.
    Xu X; Chang W; Yuan J; Han X; Tan X; Ding Y; Luo Y; Cai H; Liu Y; Gao X; Liu Q; Yu Y; Du Y; Wang H; Ma L; Wang J; Chen K; Ding Y; Fu C; Cao G
    Oncotarget; 2016 Jan; 7(1):798-813. PubMed ID: 26556874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CXCL10 expression and prognostic significance in stage II and III colorectal cancer.
    Jiang Z; Xu Y; Cai S
    Mol Biol Rep; 2010 Jul; 37(6):3029-36. PubMed ID: 19821051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
    Stanisavljević L; Myklebust MP; Leh S; Dahl O
    Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CCL20 and CXCL8 synergize to promote progression and poor survival outcome in patients with colorectal cancer by collaborative induction of the epithelial-mesenchymal transition.
    Cheng XS; Li YF; Tan J; Sun B; Xiao YC; Fang XB; Zhang XF; Li Q; Dong JH; Li M; Qian HH; Yin ZF; Yang ZB
    Cancer Lett; 2014 Jun; 348(1-2):77-87. PubMed ID: 24657657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epithelial but not stromal expression of collagen alpha-1(III) is a diagnostic and prognostic indicator of colorectal carcinoma.
    Wang XQ; Tang ZX; Yu D; Cui SJ; Jiang YH; Zhang Q; Wang J; Yang PY; Liu F
    Oncotarget; 2016 Feb; 7(8):8823-38. PubMed ID: 26741506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Potential Therapeutic Targets Among CXC Chemokines in Breast Tumor Microenvironment Using Integrative Bioinformatics Analysis.
    Chen E; Qin X; Peng K; Xu X; Li W; Cheng X; Tang C; Cui Y; Wang Z; Liu T
    Cell Physiol Biochem; 2018; 45(5):1731-1746. PubMed ID: 29495008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The expression and role of CXC chemokines in colorectal cancer.
    Verbeke H; Struyf S; Laureys G; Van Damme J
    Cytokine Growth Factor Rev; 2011; 22(5-6):345-58. PubMed ID: 22000992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetics underpinning the regulation of the CXC (ELR+) chemokines in non-small cell lung cancer.
    Baird AM; Gray SG; O'Byrne KJ
    PLoS One; 2011 Jan; 6(1):e14593. PubMed ID: 21298036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colorectal obstruction is a potential prognostic factor for stage II colorectal cancer.
    Okuda Y; Shimura T; Yamada T; Hirata Y; Yamaguchi R; Sakamoto E; Kataoka H
    Int J Clin Oncol; 2018 Dec; 23(6):1101-1111. PubMed ID: 29948240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Probing the role of CXC motif in chemokine CXCL8 for high affinity binding and activation of CXCR1 and CXCR2 receptors.
    Joseph PR; Sarmiento JM; Mishra AK; Das ST; Garofalo RP; Navarro J; Rajarathnam K
    J Biol Chem; 2010 Sep; 285(38):29262-9. PubMed ID: 20630874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative evaluation of vimentin expression in tumour stroma of colorectal cancer.
    Ngan CY; Yamamoto H; Seshimo I; Tsujino T; Man-i M; Ikeda JI; Konishi K; Takemasa I; Ikeda M; Sekimoto M; Matsuura N; Monden M
    Br J Cancer; 2007 Mar; 96(6):986-92. PubMed ID: 17325702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Significance of CXCL1 and CXCL8 as Well as Their Specific Receptors in Colorectal Cancer.
    Łukaszewicz-Zając M; Pączek S; Mroczko P; Kulczyńska-Przybik A
    Cancer Manag Res; 2020; 12():8435-8443. PubMed ID: 32982437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and function of the chemokine receptors CXCR1 and CXCR2 in sepsis.
    Cummings CJ; Martin TR; Frevert CW; Quan JM; Wong VA; Mongovin SM; Hagen TR; Steinberg KP; Goodman RB
    J Immunol; 1999 Feb; 162(4):2341-6. PubMed ID: 9973513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Soluble CXCL16 in preoperative serum is a novel prognostic marker and predicts recurrence of liver metastases in colorectal cancer patients.
    Matsushita K; Toiyama Y; Tanaka K; Saigusa S; Hiro J; Uchida K; Inoue Y; Kusunoki M
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S518-27. PubMed ID: 21845497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential usage of the CXC chemokine receptors 1 and 2 by interleukin-8, granulocyte chemotactic protein-2 and epithelial-cell-derived neutrophil attractant-78.
    Wuyts A; Proost P; Lenaerts JP; Ben-Baruch A; Van Damme J; Wang JM
    Eur J Biochem; 1998 Jul; 255(1):67-73. PubMed ID: 9692902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CCL21 as an independent favorable prognostic factor for stage III/IV colorectal cancer.
    Zou Y; Chen Y; Wu X; Yuan R; Cai Z; He X; Fan X; Wang L; Wu X; Lan P
    Oncol Rep; 2013 Aug; 30(2):659-66. PubMed ID: 23760102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.